Knight Therapeutics Inc T.GUD

ouch.. Biogen. GUD Toasted

[Chianchin]

The Food and Drug Administration on Monday approved Biogen Alzheimer’s drug aducanumab,
Why we now know why Novartis sold 

[Chianchin]

..and four more new drugs in the pipeline to replace Gud's excelon

[Snowballgrowth]

54 k$ per year vs less than 150 $ per month for Exelon ! 

[MrMugsy]

That's a really good point Snowball - especially if you're offering the product in South American countries.  Didn't even think of that issue.